» Articles » PMID: 26010484

Association Study Between the CD157/BST1 Gene and Autism Spectrum Disorders in a Japanese Population

Overview
Journal Brain Sci
Publisher MDPI
Date 2015 May 27
PMID 26010484
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

CD157, also referred to as bone marrow stromal cell antigen-1 (BST-1), is a glycosylphosphatidylinositol-anchored molecule that promotes pre-B-cell growth. Previous studies have reported associations between single-nucleotide polymorphisms (SNPs) of the CD157/BST1 gene with Parkinson's disease. In an attempt to determine whether SNPs or haplotypes in the CD157/BST1 are associated with other brain disorders, we performed a case-control study including 147 autism spectrum disorder (ASD) patients at Kanazawa University Hospital in Japan and 150 unselected Japanese volunteers by the sequence-specific primer-polymerase chain reaction method combined with fluorescence correlation spectroscopy. Of 93 SNPs examined, two SNPs showed significantly higher allele frequencies in cases with ASDs than in unaffected controls (rs4301112, OR = 6.4, 95% CI = 1.9 to 22, p = 0.0007; and rs28532698, OR = 6.2, 95% CI = 1.8 to 21, p = 0.0012; Fisher's exact test; p < 0.002 was considered significant after multiple testing correction). In addition, CT genotype in rs10001565 was more frequently observed in the ASD group than in the control group (OR = 15, 95% CI = 2.0 to 117, p = 0.0007; Fisher's exact test). The present data indicate that genetic variation of the CD157/BST1 gene might confer susceptibility to ASDs.

Citing Articles

Oral Supplementation of L-Carnosine Attenuates Acute-Stress-Induced Corticosterone Release and Mitigates Anxiety in CD157 Knockout Mice.

Tsuji T, Furuhara K, Guo E, Wu Y, Zhong J, Higashida H Nutrients. 2024; 16(17).

PMID: 39275136 PMC: 11396873. DOI: 10.3390/nu16172821.


Editorial: Revisiting immunological roles for bone marrow stromal cell antigen-1; an entero-neuro-immune regulator.

Funaro A, Nakagawa T, Ishihara K Front Immunol. 2023; 14:1239546.

PMID: 37441068 PMC: 10335351. DOI: 10.3389/fimmu.2023.1239546.


Genetic polymorphisms of bone marrow stromal cell antigen-1 (BST-1/CD157): implications for immune/inflammatory dysfunction in neuropsychiatric disorders.

Yokoyama S Front Immunol. 2023; 14:1197265.

PMID: 37313401 PMC: 10258321. DOI: 10.3389/fimmu.2023.1197265.


Remission of social behavior impairment by oral administration of a precursor of NAD in CD157, but not in CD38, knockout mice.

Gerasimenko M, Higashida H Front Immunol. 2023; 14:1166609.

PMID: 37215105 PMC: 10192747. DOI: 10.3389/fimmu.2023.1166609.


Linking autism spectrum disorders and parkinsonism: clinical and genetic association.

Mai A, Yau C, Tseng F, Foo Q, Wang D, Tan E Ann Clin Transl Neurol. 2023; 10(4):484-496.

PMID: 36738194 PMC: 10109258. DOI: 10.1002/acn3.51736.


References
1.
Ortolan E, Arisio R, Morone S, Bovino P, Lo-Buono N, Nacci G . Functional role and prognostic significance of CD157 in ovarian carcinoma. J Natl Cancer Inst. 2010; 102(15):1160-77. DOI: 10.1093/jnci/djq256. View

2.
Lai C, Fisher S, Hurst J, Vargha-Khadem F, Monaco A . A forkhead-domain gene is mutated in a severe speech and language disorder. Nature. 2001; 413(6855):519-23. DOI: 10.1038/35097076. View

3.
Yu C, Zhang S, Zhou C, Sile S . A likelihood ratio test of population Hardy-Weinberg equilibrium for case-control studies. Genet Epidemiol. 2008; 33(3):275-80. PMC: 2657816. DOI: 10.1002/gepi.20381. View

4.
Quarona V, Zaccarello G, Chillemi A, Brunetti E, Singh V, Ferrero E . CD38 and CD157: a long journey from activation markers to multifunctional molecules. Cytometry B Clin Cytom. 2013; 84(4):207-17. DOI: 10.1002/cyto.b.21092. View

5.
Wing L, Leekam S, Libby S, Gould J, Larcombe M . The Diagnostic Interview for Social and Communication Disorders: background, inter-rater reliability and clinical use. J Child Psychol Psychiatry. 2002; 43(3):307-25. DOI: 10.1111/1469-7610.00023. View